Labopharm to present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference

    LAVAL, Québec, April 5 /CNW/ - Labopharm Inc. (TSX: DDS; NASDAQ:   DDSS)
today announced that Mark D'Souza, Chief Financial Officer of the Company,
will present at the CIBC World Markets Annual Biotechnology & Specialty
Pharmaceuticals Conference in New York, on Wednesday, April 11, 2007 at 3:05
p.m. ET.

    About Labopharm Inc.

    Labopharm Inc. is an international specialty pharmaceutical company
focused on the development of drugs incorporating the Company's proprietary
advanced controlled-release technologies. The Company's lead product, a
once-daily formulation of the analgesic tramadol, has been approved and
launched in Europe and is currently under review for approval by the U.S. Food
and Drug Administration. For more information, please visit

    This press release contains forward-looking statements, which reflect the
Corporation's current expectations regarding future events. The
forward-looking statements involve risks and uncertainties. Actual events
could differ materially from those projected herein and depend on a number of
factors, including the uncertainties related to the regulatory process and the
commercialization of the Corporation's products thereafter, if they are
approved. Investors should consult the Corporation's ongoing quarterly filings
and annual reports for additional information on risks and uncertainties
relating to these forward-looking statements. The reader is cautioned not to
rely on these forward-looking statements. The Corporation disclaims any
obligation to update these forward-looking statements.

For further information:

For further information: At Labopharm, Mark D'Souza, Chief Financial
Officer, Tel: (450) 686-0207; At The Equicom Group, Jason Hogan, Media and
Investor Relations, Tel: (416) 815-0700,; French: Eric
Bouchard, Tel: (514) 844-7997,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890